Total Payments
$24,998
2024 Payments
$3,065
Companies
55
Transactions
1,119
Medicare Patients
9,729
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$21,723 (86.9%)
Travel$3,264 (13.1%)
Education$10.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,723 | 1,103 | 86.9% |
| Travel and Lodging | $3,264 | 15 | 13.1% |
| Education | $10.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,748 | 66 | $0 (2024) |
| Amgen Inc. | $2,195 | 132 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,789 | 117 | $0 (2024) |
| BIOTRONIK INC. | $1,604 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,545 | 100 | $0 (2024) |
| Medtronic, Inc. | $1,488 | 15 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $1,302 | 90 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,053 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,029 | 43 | $0 (2024) |
| Philips Electronics North America Corporation | $1,013 | 36 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,065 | 150 | Boston Scientific Corporation ($541.03) |
| 2023 | $4,830 | 179 | Medtronic, Inc. ($1,336) |
| 2022 | $4,070 | 167 | BIOTRONIK INC. ($939.70) |
| 2021 | $2,671 | 159 | Janssen Pharmaceuticals, Inc ($385.01) |
| 2020 | $2,077 | 111 | Janssen Pharmaceuticals, Inc ($336.35) |
| 2019 | $2,212 | 124 | Actelion Pharmaceuticals US, Inc. ($412.35) |
| 2018 | $2,111 | 117 | Amgen Inc. ($376.18) |
| 2017 | $3,962 | 112 | BOSTON SCIENTIFIC CORPORATION ($2,199) |
All Payment Transactions
1,119 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Philips North America LLC | (BR5) Peripheral IVUS (Device) | Food and Beverage | Cash or cash equivalent | $5.70 | General |
| Category: Medical Device | ||||||
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: WATCHMAN_IC | ||||||
| 12/11/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: WATCHMAN_IC | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug), Kerendia | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardio-pulmonary | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | Philips North America LLC | (BS1) Peripheral Vascular Undivided (Device) | Food and Beverage | Cash or cash equivalent | $13.03 | General |
| Category: Medical Device | ||||||
| 11/21/2024 | Philips North America LLC | (AZ7) Lasers (Device) | Food and Beverage | Cash or cash equivalent | $10.21 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: WATCHMAN_IC | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: WATCHMAN_IC | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $46.11 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Philips North America LLC | (BS1) Peripheral Vascular Undivided (Device) | Food and Beverage | Cash or cash equivalent | $23.23 | General |
| Category: Medical Device | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug), Kerendia | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardio-pulmonary | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.28 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,136 | 3,307 | $1.7M | $415,187 |
| 2022 | 34 | 2,177 | 3,501 | $1.3M | $400,771 |
| 2021 | 34 | 2,623 | 3,965 | $1.6M | $537,804 |
| 2020 | 39 | 2,793 | 4,258 | $1.6M | $520,257 |
Total Patients
9,729
Total Services
15,031
Medicare Billing
$1.9M
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2023 | 12 | 13 | $235,440 | $72,705 | 30.9% |
| 37225 | Removal of plaque in arteries of leg | Office | 2023 | 13 | 13 | $377,536 | $57,091 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 354 | 565 | $101,517 | $46,675 | 46.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 124 | 124 | $101,293 | $39,174 | 38.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 124 | 247 | $99,990 | $33,478 | 33.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 224 | 231 | $174,893 | $30,540 | 17.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 56 | 296 | $116,032 | $15,468 | 13.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 74 | 78 | $44,070 | $13,310 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 207 | $24,114 | $11,845 | 49.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 20 | 23 | $53,981 | $10,014 | 18.6% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 13 | 15 | $44,810 | $9,166 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 138 | $17,700 | $8,519 | 48.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 75 | $18,315 | $7,321 | 40.0% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 75 | 79 | $25,872 | $6,586 | 25.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 34 | 136 | $16,928 | $5,993 | 35.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 124 | 124 | $19,160 | $5,779 | 30.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 31 | 31 | $29,865 | $5,413 | 18.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $13,034 | $4,819 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $10,474 | $4,306 | 41.1% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 12 | 28 | $14,300 | $3,501 | 24.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 38 | 175 | $13,825 | $3,002 | 21.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 21 | 22 | $11,770 | $2,925 | 24.8% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 24 | 27 | $36,615 | $2,917 | 8.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 28 | $5,073 | $2,613 | 51.5% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 20 | 115 | $8,625 | $2,042 | 23.7% |
About Dr. Azamuddin Khaja, M.D
Dr. Azamuddin Khaja, M.D is a Cardiovascular Disease healthcare provider based in Farmington, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699723486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Azamuddin Khaja, M.D has received a total of $24,998 in payments from pharmaceutical and medical device companies, with $3,065 received in 2024. These payments were reported across 1,119 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($21,723).
As a Medicare-enrolled provider, Khaja has provided services to 9,729 Medicare beneficiaries, totaling 15,031 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Farmington, MO
- Active Since 05/04/2006
- Last Updated 12/03/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1699723486
Products in Payments
- GENERAL - VASCULAR ACCESS (Device) $2,036
- XARELTO (Drug) $1,833
- Repatha (Biological) $1,381
- MICRA (Device) $1,336
- ENTRESTO (Drug) $1,213
- ELIQUIS (Drug) $1,120
- WATCHMAN Access System (Device) $957.94
- JARDIANCE (Drug) $897.62
- LifeVest (Device) $793.04
- Corlanor (Drug) $787.35
- Rivacor 7 DR-T (Device) $673.15
- OPSUMIT (Drug) $540.25
- BRILINTA (Drug) $528.70
- UPTRAVI (Drug) $510.64
- Adempas (Drug) $483.21
- Resolute (Device) $443.41
- ZONTIVITY (Drug) $361.44
- FARXIGA (Drug) $357.51
- VERQUVO (Drug) $349.00
- Acticor 7 VR-T DX (Device) $334.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Farmington
Michael West, Md, MD
Cardiovascular Disease — Payments: $105,217
Cardiovascular Disease $105,217
Dr. Khagendra Dahal, Md, MD
Cardiovascular Disease — Payments: $41,421
Cardiovascular Disease $41,421
Juyong Lee, Md/Phd, MD/PHD
Cardiovascular Disease — Payments: $17,527
Cardiovascular Disease $17,527
Bhavananda Reddy, Md, MD
Cardiovascular Disease — Payments: $16,555
Cardiovascular Disease $16,555
Shubhi Pandey
Cardiovascular Disease — Payments: $14,499
Cardiovascular Disease $14,499
Daniel Humiston, Md, MD
Cardiovascular Disease — Payments: $11,133
Cardiovascular Disease $11,133